MALDI is the acronym for matrix-assisted laser desorption ionization. It is a type of mass spectrometry imaging that allows for label-free measurements of biological molecules such as proteins and ...
Until recently, clinical diagnostic laboratories predominantly relied on conventional phenotypic ways of diagnosing infections, and sometimes on gene sequencing techniques. The latest advancements in ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure Fast and reliable identification of ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure MALDI PharmaPulse is a complete mass ...
Matrix‐assisted laser desorption/ionisation time‐of‐flight mass spectrometry (MALDI‐TOF MS) has transformed fungal identification by offering rapid, cost‐effective and highly accurate species ...
Introducing the MALDI-2 on timsTOF fleX: MALDI-2, redefining ionization for >100x increased signal a
timsTOF fleX is now available with the innovative and powerful MALDI-2 technology option. This post-ionization technique leads to both a significant boost in ion yields and reduction in ion ...
The December 2017 issue of SLAS Discovery marks the 30 th anniversary of Matrix Assisted Laser Desorption/Ionization Time of Flight (MALDI TOF), the soft ionization technique for analyzing ...
Bruker proudly introduces the latest member of the MALDI Biotyper ® product family, the MALDI Biotyper sirius one. Bruker‘s newest sirius system unites new features with appreciated existing elements, ...
Boston-based PerkinElmer Life and Analytical Sciences has released the prOTOF™ 2000, the first commercially available matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass ...
Mass spectrometry has long been recognized as one of the leading analytical tools for the rapid characterization of biological macromolecules. The imaging function of mass spectrometry combines the ...
Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX. The agreement enables the validation of Bruker’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results